93 related articles for article (PubMed ID: 17714037)
1. Sunitinib (sutent)-induced thyrotoxicosis due to destructive thyroiditis: a case report.
Faris JE; Moore AF; Daniels GH
Thyroid; 2007 Nov; 17(11):1147-9. PubMed ID: 17714037
[TBL] [Abstract][Full Text] [Related]
2. Sunitinib-induced thyrotoxicosis followed by persistent hypothyroidism with shrinkage of thyroid volume.
Sakurai K; Fukazawa H; Arihara Z; Yoshida K
Tohoku J Exp Med; 2010 Sep; 222(1):39-44. PubMed ID: 20814176
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of thyroid abnormalities induced by sunitinib treatment in Japanese patients with renal cell carcinoma.
Sato S; Muraishi K; Tani J; Sasaki Y; Tokubuchi I; Tajiri Y; Yamada K; Suekane S; Miyajima J; Matsuoka K; Hiromatsu Y
Endocr J; 2010; 57(10):873-80. PubMed ID: 20733268
[TBL] [Abstract][Full Text] [Related]
4. Thyrotoxicosis during sunitinib treatment for renal cell carcinoma.
Grossmann M; Premaratne E; Desai J; Davis ID
Clin Endocrinol (Oxf); 2008 Oct; 69(4):669-72. PubMed ID: 18394019
[TBL] [Abstract][Full Text] [Related]
5. Sunitinib-induced thyrotoxicosis - a not so rare entity.
Jazvić M; Prpić M; Jukić T; Murgić J; Jakšić B; Kust D; Prgomet A; Bolanča A; Kusić Z
Anticancer Res; 2015 Jan; 35(1):481-5. PubMed ID: 25550591
[TBL] [Abstract][Full Text] [Related]
6. Sunitinib-induced autoimmune thyroiditis in a patient with metastatic renal cell carcinoma: a case report.
Babacan T; Sevinc A; Akarsu E; Balakan O
Chemotherapy; 2012; 58(2):142-5. PubMed ID: 22584361
[TBL] [Abstract][Full Text] [Related]
7. Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors.
Desai J; Yassa L; Marqusee E; George S; Frates MC; Chen MH; Morgan JA; Dychter SS; Larsen PR; Demetri GD; Alexander EK
Ann Intern Med; 2006 Nov; 145(9):660-4. PubMed ID: 17088579
[TBL] [Abstract][Full Text] [Related]
8. A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake.
Mannavola D; Coco P; Vannucchi G; Bertuelli R; Carletto M; Casali PG; Beck-Peccoz P; Fugazzola L
J Clin Endocrinol Metab; 2007 Sep; 92(9):3531-4. PubMed ID: 17595247
[TBL] [Abstract][Full Text] [Related]
9. Summaries for patients. Underactive thyroid function after treatment with sunitinib for gastrointestinal cancer.
Ann Intern Med; 2006 Nov; 145(9):I44. PubMed ID: 17088575
[No Abstract] [Full Text] [Related]
10. Sunitinib-induced thyrotoxicosis.
Piñar D; Boix E; Meana JA; Herrero J
J Endocrinol Invest; 2009 Dec; 32(11):941-2. PubMed ID: 19636224
[No Abstract] [Full Text] [Related]
11. Guillain-Barré syndrome after treatment with sunitinib malate?
Mulherin B; Loconte NK; Holen KD
Oncology (Williston Park); 2008 Jan; 22(1):66-7, 70-1. PubMed ID: 18251284
[TBL] [Abstract][Full Text] [Related]
12. Acute thyrotoxicosis secondary to destructive thyroiditis associated with cardiac catheterization contrast dye.
Calvi L; Daniels GH
Thyroid; 2011 Apr; 21(4):443-9. PubMed ID: 21385076
[TBL] [Abstract][Full Text] [Related]
13. Sunitinib-induced acute severe hypothyroidism in a case of metastatic gastrointestinal stromal tumor: A case report.
Manir KS; Banerjee D; Bhowmick R; Roy C
J Cancer Res Ther; 2018 Sep; 14(Supplement):S818-S819. PubMed ID: 30249914
[TBL] [Abstract][Full Text] [Related]
14. Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid.
Roti E; Minelli R; Gardini E; Bianconi L; Braverman LE
Arch Intern Med; 1993 Apr; 153(7):886-92. PubMed ID: 8466380
[TBL] [Abstract][Full Text] [Related]
15. Sunitinib-induced severe hypothyroidism with cardiac compromise.
Collinson FJ; Vasudev NS; Berkin L; Khan MM; Selby PJ; Brown JE
Med Oncol; 2011 Dec; 28 Suppl 1():S699-701. PubMed ID: 21116874
[TBL] [Abstract][Full Text] [Related]
16. Destructive thyroiditis presenting as thyrotoxicosis followed by hypothyroidism during lenvatinib therapy for hepatocellular carcinoma.
Suoh M; Fujii H; Nagata Y; Kotani K; Hagihara A; Enomoto M; Tamori A; Inaba M; Kawada N
Clin J Gastroenterol; 2020 Oct; 13(5):860-866. PubMed ID: 32128670
[TBL] [Abstract][Full Text] [Related]
17. Transient thyrotoxicosis from thyroiditis induced by sibutramine overdose: a case report.
Kim SK; Lee SM; Yoo SS; Hahm JR; Jung JH; Kim HS; Kim S; Chung SI; Jung TS
Hum Exp Toxicol; 2013 Aug; 32(8):890-2. PubMed ID: 23703820
[TBL] [Abstract][Full Text] [Related]
18. Inappropriate elevation of serum thyrotropin levels in patients treated with axitinib.
Ohba K; Takayama T; Matsunaga H; Matsushita A; Sasaki S; Oki Y; Ozono S; Nakamura H
Thyroid; 2013 Apr; 23(4):443-8. PubMed ID: 23157669
[TBL] [Abstract][Full Text] [Related]
19. Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.
Rini BI; Tamaskar I; Shaheen P; Salas R; Garcia J; Wood L; Reddy S; Dreicer R; Bukowski RM
J Natl Cancer Inst; 2007 Jan; 99(1):81-3. PubMed ID: 17202116
[TBL] [Abstract][Full Text] [Related]
20. [Sunitinib and hypothyroidism].
Cohen R; Bihan H; Uzzan B; des Guetz G; Krivitzky A
Ann Endocrinol (Paris); 2007 Oct; 68(5):332-6. PubMed ID: 17707761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]